control group:The placebo
Sponsors
Beijing Institute of Traditional Chinese Medicine, Beijing Hospital of Traditional Chinese Medicine, Affiliated to the Capital Medical University, The Third Affiliated Hospital of Beijing University of Chinese Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Nanjing General Hospital of Nanjing Military Command
Conditions
COPDChronic obstructive pulmonary diseaseMyelodysplastic syndromePerimenopausal syndromecoronary heart diseasevitamin D deficienct and insufficienct women in vitro fertilization and embryo transfer (IVF)
Early Phase 1
Clinical study on improving ovarian function of women with perimenopausal syndrome by Zishui Qinggan Lichong Decoction
Active, not recruitingITMCTR2000002899
Start: 2020-02-01Updated: 2023-02-20
Clinical study on improving ovarian function of women with perimenopausal syndrome by Zishui Qinggan Lichong Decoction
Active, not recruitingChiCTR2000028823
Start: 2020-02-01Updated: 2020-01-06
A randomized, double-blind controlled trial for sanzihuangshi pill in the treatment of relatively low-risk myelodysplastic syndromes
Active, not recruitingChiCTR2000037413
Start: 2021-02-01Updated: 2020-10-13
A randomized, double-blind controlled trial for sanzihuangshi pill in the treatment of relatively low-risk myelodysplastic syndromes
Active, not recruitingITMCTR2000003808
Start: 2021-02-01Updated: 2023-02-20
Phase 1
Phase 2
Unknown Phase
Analysis of pregnancy outcome of Afar calciferol treating vitamin D deficienct and insufficienct women in vitro fertilization and embryo transfer (IVF) .
RecruitingChiCTR-INR-16008188
Start: 2016-04-01Updated: 2017-04-18
Clinical study of eliminating dampness and phlegm treatment for angina pectoris after revascularization of coronary heart disease
RecruitingChiCTR2000040270
Start: 2020-12-01Updated: 2021-08-30
Clinical study of eliminating dampness and phlegm treatment for angina pectoris after revascularization of coronary heart disease
RecruitingITMCTR2000004085
Start: 2020-12-01Updated: 2023-02-20